RecruitingPhase 3NCT06140927

Effect of Ketamine on Intraoperative Motor Evoked Potentials


Sponsor

University of California, San Francisco

Enrollment

20 participants

Start Date

Dec 1, 2023

Study Type

INTERVENTIONAL

Conditions

Summary

The goal of this clinical trial is to learn about the effect of ketamine on intraoperative motor evoked potentials in adult patients undergoing thoracolumbar spinal fusions. Participants will undergo a standard anesthetic. In addition to the standard anesthetic, the patients will be administered increasing doses of ketamine with motor-evoked potentials being measured at each dose, to assess any impacts.


Eligibility

Min Age: 18 YearsMax Age: 100 Years

Inclusion Criteria1

  • Adult patients (\>18 years of age) undergoing posterior spinal fusions.

Exclusion Criteria6

  • Sensitivity or allergy to ketamine.
  • Schizophrenia or other psychotic conditions
  • Uncontrolled hypertension with systolic blood pressure greater than 180 mmHg
  • Myocardial Infarction
  • Large vascular aneurysms
  • Patients on ketamine as outpatient therapy.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGKetamine

Patients will be administered ketamine at increasing doses followed by measurements of motor-evoked potentials.


Locations(1)

University of California, San Francisco

San Francisco, California, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06140927


Related Trials